Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
Date:5/2/2013

his new treatment option available to patients in additional parts of the world."

APD811 

  • Initiated dosing of an additional cohort in a Phase 1 multiple dose clinical trial of APD811, an oral drug candidate that targets the prostacyclin (IP) receptor for the potential treatment of pulmonary arterial hypertension (PAH). This randomized, double-blind and placebo-controlled trial is designed to evaluate the safety, tolerability and pharmacokinetics of multiple-ascending doses of APD811 and to optimize the dosing regimen prior to potentially initiating a Phase 2 clinical trial.
  • APD334

  • Initiated dosing in a Phase 1 clinical trial of APD334, an oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P1) receptor for the potential treatment of various autoimmune diseases. This randomized, double-blind and placebo-controlled Phase 1 trial is designed to evaluate the safety, tolerability and pharmacokinetics of single-ascending doses of APD334.
  • "We are leveraging our validated research and development capabilities to continue to build and advance our pipeline of innovative drug candidates," said William R. Shanahan , M.D., Arena's Senior Vice President and Chief Medical Officer. "With APD811 and APD334, we look forward to potentially expanding the options available to patients and physicians for the treatment of PAH and certain autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis and psoriasis."

    First Quarter 2013 Financial Results Arena recognized revenues totaling $2.4 million in the first quarter of 2013, compared to $2.2 million in the first quarter of 2012. The revenue recognized in 2013 includes a $500,000 milestone payment earned from Eisai upon filing the BELVIQ MAA in Mexico.

    Research and development expenses in the first quarter of 2013 decreased to $14.0 million, compared to $14.5 million in the f
    '/>"/>

    SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Arena Pharmaceuticals Announces First Quarter 2012 Financial Results and Recent Developments
    2. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
    3. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
    4. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
    5. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
    6. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
    7. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
    8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
    9. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
    10. Arena Pharmaceuticals to Present at Upcoming Investor Conferences
    11. Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2014)... TWi Pharmaceuticals, Inc. (4180.TT) today announced that ... States Food and Drug Administration (FDA) on its ... 125mg/ml oral suspension, the generic equivalent to Par ... under Hatch Waxman rules, it will be entitled ... completed the pre-launch preparation of the generic drug.  ...
    (Date:8/27/2014)... Reportbuyer.com has added a new ... Terms & Agreements in Pharma, Biotech and ... The Collaborative R&D Terms and Agreements in ... understanding and unprecedented access to the collaborative ... the worlds leading life science companies. ...
    (Date:8/27/2014)... LONDON , Aug. 27, 2014 /PRNewswire/ ... research report: Co-development Terms & ... https://www.reportbuyer.com/product/2276221/Co-development-Terms--Agreements-in-Pharma-Biotech-and-Diagnostics.html The ... and Diagnostics report provides comprehensive understanding and ... agreements entered into by the worlds leading ...
    Breaking Medicine Technology:TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 3Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 4Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 5Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 6Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 7Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 8Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 9Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 2Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 3Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 4Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 5Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 6Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 7
    ... Cell Therapy, Inc. ("Pathfinder")(OTCQB: PFND), a biotechnology company focused ... damage, today announced that effective at the start of ... will change from SYMD to PFND.  The new ticker ... and has been approved by the Financial Industry Regulatory ...
    ... /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... medical devices worldwide, today announced the introduction of the ... The black and white portable unit provides outstanding imaging ... use in numerous specialty markets. With DP-50,s launch, Mindray ...
    Cached Medicine Technology:Pathfinder Cell Therapy, Inc. Announces New Stock Ticker Symbol 2Mindray Introduces DP-50 Portable Ultrasound System in the U.S. 2Mindray Introduces DP-50 Portable Ultrasound System in the U.S. 3
    (Date:8/27/2014)... 2014 According to a new market ... Market (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic ... Trends and Forecast 2014 - 2020", the global surgical ... in 2013 and is expected to grow at a ... an estimated value of USD 295.5 million in 2020. ...
    (Date:8/27/2014)... 28, 2014 Spine Guide has built ... of information on spinal health. Now, the e-health site ... people suffering from back pain symptoms. Spine Guide specializes ... surgery, and lumbar spine surgery. , Some of the ... or stabbing pain, pain radiating down the leg, inability ...
    (Date:8/27/2014)... Recently, BambooIndustry.com, an innovative company that provides many kinds of ... panels are now offered on its website. In addition, ... All people that place an order for its newly released ... percent off. , The company’s senior spokesman was excited ... our new and old customers can buy cheap bamboo panels ...
    (Date:8/27/2014)... (PRWEB) August 27, 2014 ... dental plans, has launched in the state of ... to quality, affordable dental care services at reduced ... for Tennessee consumers looking to save money on ... rates as a member of discount fee dental ...
    (Date:8/27/2014)... 28, 2014 DiaSorin has announced that ... 1,25 Dihydroxyvitamin D,” will feature guest speaker Dr. Gregory ... Institute for Health and Healing Integrative Medicine. Dr. Plotnikoff ... George Institute for Health and Healing and as Senior ... Minneapolis, Minnesota. He also serves as a co-editor of ...
    Breaking Medicine News(10 mins):Health News:Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 2Health News:Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 3Health News:Spine Guide Offering New Overview of Surgical Options For Back Pain 2Health News:BambooIndustry.com: Cheap Bamboo Panels for Clients Worldwide Offered Online 2Health News:DentistSave.com Launches Discount Dental Plans in Tennessee for Consumers, Businesses, and Groups 2Health News:DentistSave.com Launches Discount Dental Plans in Tennessee for Consumers, Businesses, and Groups 3Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 2Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 3
    ... is this year,s Miss Fairfield County. The Connecticut ... volunteer,patient care activities over these last two years, ... compassion for those that are suffering has been,extraordinary, ... pediatric patients or,to our young or mature adults," ...
    ... celebrates its one-year anniversary with a donation to Dress for ... ... than four,million people get a new lease on life, alli(R) is celebrating ... was made today at a press event in New York., (Logo: ...
    ... an association between examiner qualifications and device quality on ... tests in pregnancy on the other. However, it is ... to achieve sufficiently high detection rates for major foetal ... the association described in other health care systems also ...
    ... 24 At this year,s annual telethon,for Alex,s ... MIKE AND,IKE(R) Candy Brand presented the Alex,s Lemonade ... a multi-year commitment to this foundation., (Photo: ... Lemonade Blends(TM) kicks off Just Born,s partnership,with the ...
    ... Federal Rule Changes ... Tools, CHICAGO, June 24 Allscripts, the ... physicians use,to improve healthcare, announced today that it ... Hospital Presbyterian in Newport Beach,Calif. preferred pricing on ...
    ... and community ... health centers., REDMOND, ... delivered to medically underserved,D.C. residents, the District of Columbia Primary Care ... the,sharing of data among local hospitals and six community-based health,centers that ...
    Cached Medicine News:Health News:Connecticut Hospice Has Miss Fairfield on Its Side 2Health News:Connecticut Hospice Has Miss Fairfield on Its Side 3Health News:One Year Later, Millions are Losing Weight with alli(R) 2Health News:One Year Later, Millions are Losing Weight with alli(R) 3Health News:Accuracy of ultrasound screening in pregnancy: Effects of examiner and device quality unclear 2Health News:Accuracy of ultrasound screening in pregnancy: Effects of examiner and device quality unclear 3Health News:MIKE AND IKE(R) Lemonade Blends(TM) Presents $100,000 to Alex's Lemonade Stand Foundation 2Health News:Hoag Memorial Hospital Presbyterian Selects Allscripts for Electronic Health Record Subsidy Program 2Health News:Hoag Memorial Hospital Presbyterian Selects Allscripts for Electronic Health Record Subsidy Program 3Health News:District of Columbia Primary Care Association Selects Microsoft Amalga to Improve Patient Care for the Underserved 2Health News:District of Columbia Primary Care Association Selects Microsoft Amalga to Improve Patient Care for the Underserved 3
    The Continuous Wave II Arthroscopy Pump provides pulse-free, continuous fluid inflow for joint distention when used in conjunction with a high flow sheath or separate inflow cannula....
    True/Fix Distal Femoral Nail System...
    ... important part in our daily lives. But ... can cause severe handicaps. A decisive consideration ... was to produce a reconstructed joint function ... nearly possible.,The cementless RM Finger System has ...
    ... to use vacuum mixing, simplicity is still the ... & Nephew.,Simple To Choose: the two options available ... and leverage to determine which approach is better ... easy to inventory, and easy to use - ...
    Medicine Products: